Dr. Lesokhin on the Current Treatment Landscape of Myeloma

Dr. Anderson on Future Treatment Landscape of Multiple MyelomaПодробнее

Dr. Lesokhin Discusses Exciting Advances in Multiple MyelomaПодробнее

Alexander Lesokhin, MD explains therapy combinations for newly diagnosed multiple myeloma patientsПодробнее

Alexander Lesokhin, MD talks about newly diagnosed multiple myeloma patientsПодробнее

The trends in outcomes after upfront autoSCT for multiple myeloma over three decadesПодробнее

Highlights at ASH 2022: the promise of T-cell redirecting therapies in multiple myelomaПодробнее

Current treatment landscape of newly diagnosed multiple myelomaПодробнее

Current treatment landscape of myelomaПодробнее

Multiple Myeloma Immunotherapy: Where Are We Now, with Alexander LesokhinПодробнее

How immunotherapies are changing the myeloma treatment landscape & future outlooksПодробнее

The future of myeloma therapy and where the treatment landscape is movingПодробнее

Alexander Lesokhin, MD talks about the pros/cons of an all-oral regimen in the treatment of MMПодробнее

The evolution of the myeloma treatment landscapeПодробнее

Myeloma Crowd Radio: Alexander Lesokhin, MD, Memorial Sloan Kettering CCПодробнее

The future myeloma treatment landscapeПодробнее

The current treatment landscape in multiple myelomaПодробнее

Alexander Lesokhin, MD on the use of daratumumab to treat multiple myeloma patientsПодробнее

Alexander Lesokhin, MD on sequencing therapies in relapsed multiple myeloma patientsПодробнее

Alexander Lesokhin, MD discusses the development of immunotherapies for multiple myeloma patientsПодробнее